Funding, projects and partnerships
We fund promising research in our Translational Challenges.
If you’re looking for ways to fund your initiative, please get in touch about partnering with us.
Find details of our partnerships and open funding calls, including eligibility criteria, below.
Search partnerships, funding calls and projects
Refine results
-
LifeArc Translational Centres for Rare Diseases
Partnerships and initiativesMore information: LifeArc Translational Centres for Rare Diseases -
Grand Challenges African Drug Discovery Accelerator programme
Partnerships and initiativesMore information: Grand Challenges African Drug Discovery Accelerator programme -
FIND
Partnerships and initiativesMore information: FIND -
ReACT Africa
Partnerships and initiativesMore information: ReACT Africa -
The Francis Crick Institute and the Crick Africa Network
Partnerships and initiatives, Funded research projectsMore information: The Francis Crick Institute and the Crick Africa Network -
PACE: Pathways to Antimicrobial Clinical Efficacy
Closed funding calls, Partnerships and initiativesMore information: PACE: Pathways to Antimicrobial Clinical Efficacy -
TB-MBLA
Partnerships and initiativesMore information: TB-MBLA -
LifeArc-CSO fund for Scottish translational researchers
Closed funding calls, Partnerships and initiativesMore information: LifeArc-CSO fund for Scottish translational researchers -
LifeArc gene therapy innovation fund
Open funding calls, Partnerships and initiativesMore information: LifeArc gene therapy innovation fund -
LifeArc and GOSH charity fund
Closed funding calls, Partnerships and initiativesMore information: LifeArc and GOSH charity fund -
LifeArc and Action medical research fund
Closed funding calls, Partnerships and initiativesMore information: LifeArc and Action medical research fund -
LifeArc Philanthropic fund
Open funding calls, Partnerships and initiativesMore information: LifeArc Philanthropic fund -
Repurposing therapies for EB
Closed funding calls, Partnerships and initiativesMore information: Repurposing therapies for EB -
Translational rare disease centres
Closed funding calls, Partnerships and initiativesMore information: Translational rare disease centres -
Muscular Dystrophy Translational Research Fund
Closed funding calls, Partnerships and initiativesMore information: Muscular Dystrophy Translational Research Fund -
£3m fund for CF therapies
Closed funding calls, Partnerships and initiativesMore information: £3m fund for CF therapies -
Drug repurposing call to treat chronic respiratory infection
Closed funding calls, Partnerships and initiativesMore information: Drug repurposing call to treat chronic respiratory infection -
£30m partnership with UK DRI
Partnerships and initiativesMore information: £30m partnership with UK DRI -
The MND Insights Group and community surveys
Partnerships and initiativesMore information: The MND Insights Group and community surveys -
The MND collaborative partnership
Closed funding calls, Partnerships and initiativesMore information: The MND collaborative partnership -
Development of Repurposed Drug Candidates for MND
Open funding callsMore information: Development of Repurposed Drug Candidates for MND -
£1m Primer Fund to accelerate MND diagnosis
Closed funding callsMore information: £1m Primer Fund to accelerate MND diagnosis -
The MND Translational Research Fund
Closed funding calls, Partnerships and initiativesMore information: The MND Translational Research Fund
Contact us
In submitting your personal data via this form, you consent to being contacted via the details provided so that your enquiry can be responded to. If you would like your data to be removed, please email dataprivacy@lifearc.org.
Please see our Privacy Policy in relation to the personal data you submit to us through this page.
Latest news
-
LifeArc launches £40m research centres that will unlock new tests, treatments and cures for people living with rare diseases
Read more: LifeArc launches £40m research centres that will unlock new tests, treatments and cures for people living with rare diseases -
First-of-a-kind plan announced to get more children access to cutting-edge, proven gene therapy treatments for rare diseases
Read more: First-of-a-kind plan announced to get more children access to cutting-edge, proven gene therapy treatments for rare diseases -
New £6.2m partnership will help to eliminate a deadly disease affecting children and vulnerable people in Kenya
Read more: New £6.2m partnership will help to eliminate a deadly disease affecting children and vulnerable people in Kenya